SPOTLIGHT: Chantix scrips drop 5% on FDA alert


Prescriptions for Pfizer's stop-smoking drug Chantix dropped 5 percent last week after the FDA called it "increasingly likely" that there is a link between use of the drug and various neuro-psychiatric symptoms, including suicidal behavior. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.